MRI-guided Focal laser ablation (FLA) is used to treat prostate cancer. Contrast enhanced imaging can assess the ablated region, but cannot be used during ablation due to effects of high energy ultrasound on MRI contrast agent stability. Our results show that high resolution MR spectroscopic imaging of the water resonance detects changes in T2* and water resonance peak amplitude that clearly delineate the ablation zone without contrast agent injection. Ablation zones measured by MR spectroscopic imaging are consistent with contrast enhanced images. This suggests that MR spectroscopic imaging can guide FLA during ablation to dynamically optimize treatment and improve outcomes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords